Results 1 to 10 of about 16,153 (165)

Implementation of a clinical decision support tool to improve the adequate prescription of low-molecular-weight heparins in non-surgical patients. [PDF]

PLoS ONE
BackgroundNon-surgical hospitalized patients have an increased risk of developing venous thromboembolism (VTE). This risk can be reduced by thromboprophylaxis with low-molecular-weight heparins (LMWHs), but adherence to thromboprophylaxis guidelines is ...
Froucke van Gosliga, Dagmar Pals, Annette van Ojik, Eric van Roon   +3 more
doaj   +2 more sources

Efficacy of thromboprophylaxis following stage II surgical palliation for single-ventricle physiology: A systematic review and meta-analysis [PDF]

Annals of Pediatric Cardiology
Background: Postoperative thrombosis remains a significant cause of mortality and morbidity, especially in patients with single-ventricle physiology (SVP).
Dicky Fakhri, Maura Andini Setiabudi, Ketut Shri Satya Yogananda   +2 more
doaj   +2 more sources

Antepartum and Postpartum Thromboprophylaxis Preferences: Insights From a Single‐Center Survey [PDF]

Health Science Reports
Background Venous thromboembolism (VTE) is a significant contributor to maternal morbidity and mortality worldwide. Thromboprophylaxis guidelines are critical for VTE prevention, yet the optimal implementation of risk‐appropriate thromboprophylaxis ...
Zwidorulwa Rabali, Haroun A. Rhemtula, Elise Schapkaitz   +2 more
doaj   +2 more sources

Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort

Research and Practice in Thrombosis and Haemostasis, 2021
Background Hospital‐associated venous thromboembolism (HA‐VTE) can be prevented by pharmacologic thromboprophylaxis. Thrombotic risk assessment models (RAMs) are essential tools to improve inadequately prescribed thromboprophylaxis. Among cases of HA‐VTE,
Marc Blondon, Andreas Limacher, Marc Righini, Drahomir Aujesky, Marie Méan   +4 more
doaj   +1 more source

Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation

Research and Practice in Thrombosis and Haemostasis, 2022
Up to about 60% of venous thromboembolic events in a community are associated with hospitalization, and most can be prevented by appropriate thromboprophylaxis.
Bruno Ávila Ferreira, Marcos deBastos, Suely Meireles Rezende   +2 more
doaj   +1 more source

Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study

Thrombosis Journal, 2022
Background Critically ill patients in intensive care units (ICUs) are at high risk of venous thromboembolism (VTE). This study aimed to explore the prophylaxis effect under a guideline-based thromboprophylaxis protocol among critically ill patients in a ...
Xiao Tang, Wen-Rui Lyu, Yu Jin, Rui Wang, Xu-Yan Li, Ying Li, Chun-Yan Zhang, Wei Zhao, Zhao-Hui Tong, Bing Sun   +9 more
doaj   +1 more source

Thromboprophylaxis in primary shoulder arthroplasty does not seem to prevent death: a report from the Norwegian Arthroplasty Register 2005–2018

Acta Orthopaedica, 2021
Background and purpose — There is still no consensus on whether to use thromboprophylaxis as a standard treatment in shoulder replacement surgery. We investigated the use of thromboprophylaxis reported to the Norwegian Arthroplasty Register (NAR).
Randi M Hole, Anne Marie Fenstad, Jan-Erik Gjertsen, Stein A Lie, Ove Furnes   +4 more
doaj   +1 more source

Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Orphanet Journal of Rare Diseases, 2022
Background Cushing’s syndrome (CS) is associated with an hypercoagulable state and an increased risk of venous thromboembolism (VTE). Evidence-based guidelines on thromboprophylaxis strategies in patients with CS are currently lacking.
F. M. van Haalen, M. Kaya, I. C. M. Pelsma, O. M. Dekkers, N. R. Biermasz, S. C. Cannegieter, M. V. Huisman, B. J. M. van Vlijmen, R. A. Feelders, F. A. Klok, A. M. Pereira, Endo-ERN Cushing and Thrombosis study group   +11 more
doaj   +1 more source

Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center

Saudi Pharmaceutical Journal, 2021
Introduction: Appropriate prescribing of thromboprophylaxis according to guidelines’ recommendations can heighten over- or underutilization risk. The study intended to evaluate the safety and effectiveness of appropriate/inappropriate thromboprophylaxis ...
Ghazwa B. Korayem, Omar A. Alshaya, Norah S. Alsubaie, Dalal A. Alabdulkarim, Omar A. Almohammed, Osamah M. Alfayez, Majed S. Al Yami   +6 more
doaj   +1 more source

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C

Research and Practice in Thrombosis and Haemostasis, 2022
Background Limited data exist about effective regimens for pharmacological thromboprophylaxis in children with acute coronavirus disease 2019 (COVID‐19) and multisystem inflammatory syndrome in children (MIS‐C).
Anna H. Schmitz, Kelly E. Wood, Elliot L. Burghardt, Bryan P. Koestner, Linder H. Wendt, Aditya V. Badheka, Anjali A. Sharathkumar   +6 more
doaj   +1 more source